No hidden fees – just official clinic prices. Pay at the clinic for Desmoid Tumor treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Desmoid Tumor treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Desmoid Tumor treatment journey.
Dr Chaitainya Borde is an expert in nuclear medicine at HCG Manavata Cancer Centre, having managed over 30,000 PET-CT scans for precise cancer monitoring.
Professor Raj Nagarkar has performed over 50,000 cancer surgeries and holds a prestigious fellowship from the Royal College of Surgeons, Edinburgh.
Dr Shruti Kate was a consultant at the world-recognised Tata Memorial Hospital before joining HCG Manavata Cancer Centre. She specialises in medical oncology for both solid tumours and paediatric cases.
Specialised desmoid tumour care in India is concentrated at major oncology centres. They have multidisciplinary sarcoma units. Leading facilities like Tata Memorial Hospital and HCG Manavata Cancer Centre provide targeted therapies and active surveillance protocols. These centres employ surgical and medical oncologists with extensive experience managing rare fibromatosis cases.
Bookimed Expert Insight: Many patients overlook the benefit of metronomic therapy in India. This treatment is a low-cost, effective alternative to aggressive surgery. Leading specialists like Dr Shruti Kate at HCG Manavata Cancer Centre are experts in these systemic treatments. This approach is particularly valuable. Desmoid tumours have high local recurrence rates after surgical removal.
Patient Consensus: Patients in India recommend a watch-and-wait approach before considering surgery. They also suggest verifying that oncologists have specific desmoid experience. Many note that oral therapies like Sorafenib can significantly shrink tumours. These therapies avoid the risks of invasive procedures.